{"id":83223,"date":"2023-04-29T14:07:03","date_gmt":"2023-04-29T14:07:03","guid":{"rendered":"https:\/\/haberulus.net\/?p=83223"},"modified":"2023-04-29T14:07:03","modified_gmt":"2023-04-29T14:07:03","slug":"obezite-tarihe-mi-karisiyor-kilo-verenlerin-goruntuleri-heyecan-yaratti","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=83223","title":{"rendered":"Obezite tarihe mi kar\u0131\u015f\u0131yor: Kilo verenlerin g\u00f6r\u00fcnt\u00fcleri heyecan yaratt\u0131"},"content":{"rendered":"

\u00d6nde gelen bir ila\u00e7 firmas\u0131n\u0131n, tip 2 \u015feker hastal\u0131\u011f\u0131n\u0131n tedavisi i\u00e7in onaylanan ve Mounjaro ticari ad\u0131yla sat\u0131\u015fa sundu\u011fu ilac\u0131n tip 2 \u015feker hastal\u0131\u011f\u0131 olan a\u015f\u0131r\u0131 kilolu ya da obez ki\u015filerin 17 ay i\u00e7inde beden a\u011f\u0131rl\u0131klar\u0131n\u0131n y\u00fczde 16\u2019s\u0131na denk gelen ortalama 15 kilo kaybetmesine yard\u0131mc\u0131 oldu\u011funu a\u00e7\u0131klad\u0131.<\/span><\/p>\n

\"\"<\/p>\n

\u0130lac\u0131 doktor kontrol\u00fcnde kullanan ki\u015filerin kilo kayb\u0131 g\u00f6zle g\u00f6r\u00fcl\u00fcr bir fark yaratt\u0131\u2026<\/p>\n<\/div>\n

VOA T\u00fcrk\u00e7e\u2019nin aktard\u0131\u011f\u0131 habere g\u00f6re, ilac\u0131n ileri a\u015fama deneylerinde, tip 2 \u015feker hastal\u0131\u011f\u0131 olmayan ve testlere kat\u0131lan benzer nitelikli denekler, haftal\u0131k enjeksiyon \u015feklinde uygulanan ila\u00e7la, yine 17 ayl\u0131k s\u00fcre i\u00e7inde beden a\u011f\u0131rl\u0131klar\u0131n\u0131n y\u00fczde 22\u2019sini kaybetti. \u0130lac\u0131 en y\u00fcksek dozda kullanan tipik bir obezite hastas\u0131 i\u00e7in bu, 17 ayda 22 kilo vermek anlam\u0131na geliyor.<\/span><\/p>\n

\"\"<\/p>\n

Kilo sorunu ya\u015fayan bir kad\u0131n\u0131n ila\u00e7 kullanmadan \u00f6nceki hali\u2026<\/p>\n<\/div>\n

Firma ad\u0131na konu\u015fan Dr. Nadia Ahmad, \u015feker hastal\u0131\u011f\u0131n\u0131n zay\u0131flamay\u0131 \u00e7ok zorla\u015ft\u0131rd\u0131\u011f\u0131n\u0131, bu nedenle deneylerden elde edilen sonu\u00e7lar\u0131n \u00f6zellikle \u00f6nemli oldu\u011funu s\u00f6yledi ve \u201cKilo kayb\u0131nda bu derece ilerlemeyi daha \u00f6nce g\u00f6rmedik\u201d dedi.<\/span><\/p>\n

\"\"<\/p>\n

\u0130lac\u0131 kulland\u0131ktan sonra zay\u0131flayan kad\u0131n\u0131n son hali be\u011feni toplad\u0131\u2026<\/p>\n<\/div>\n

K\u0130LO KONTROL\u00dc AMACIYLA ONAY ALMASI BEKLEN\u0130YOR<\/b><\/p>\n

Hen\u00fcz tamam\u0131 yay\u0131nlanmayan yeni sonu\u00e7lara at\u0131fta bulunan yetkilileri, kimyasal ad\u0131 tirzepatide olan ilac\u0131n kilo kontrol\u00fc amac\u0131yla sat\u0131\u015fa sunulmas\u0131n\u0131 h\u0131zland\u0131rmak i\u00e7in ABD G\u0131da ve \u0130la\u00e7 Dairesi\u2019ne (FDA) yapacaklar\u0131 ba\u015fvuruya son halini vereceklerini s\u00f6yledi.\u00a0<\/span><\/p>\n

S\u00f6z konusu ila\u00e7, zay\u0131flama ama\u00e7l\u0131 onay almas\u0131 durumunda, obezite tedavisinde devrim yapan tedavi y\u00f6ntemleri aras\u0131nda \u015fimdiye kadarki en etkili y\u00f6ntem olarak piyasada yerini alabilir. Her 10 Amerikal\u0131\u2019dan 4\u2019\u00fcn\u00fc etkileyen obezite, \u00f6l\u00fcme bile yol a\u00e7abilen bir\u00e7ok hastal\u0131kla ilintili.<\/span><\/p>\n

Massachusetts eyaletinin Boston kentindeki Brigham and Women\u2019s Hastanesi\u2019nden Kilo Kontrol\u00fc Merkezi Direkt\u00f6r\u00fc Dr. Caroline Apovian, \u201cE\u011fer bu \u00fclkede herkes beden a\u011f\u0131rl\u0131\u011f\u0131n\u0131n y\u00fczde 20\u2019sini verse bu hastalar\u0131n refl\u00fc, \u015feker, tansiyon ila\u00e7lar\u0131n\u0131 kesebiliriz. Hastalar\u0131 kalp stentlerinin yenilenmesi i\u00e7in hastaneye sevk etmek zorunda kalmay\u0131z\u201d a\u00e7\u0131klamas\u0131nda bulundu.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Ara\u015ft\u0131rmac\u0131lar\u0131n \u00fczerinde \u00e7al\u0131\u015ft\u0131\u011f\u0131 g\u00fc\u00e7l\u00fc bir obezite ilac\u0131n\u0131n, zay\u0131flama sekt\u00f6r\u00fcnde \u00e7\u0131\u011f\u0131r a\u00e7abilecek niteliklere sahip oldu\u011fu iddia ediliyor.<\/p>\n","protected":false},"author":1,"featured_media":83224,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[1564,1132,243,631],"class_list":["post-83223","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-ilac","tag-ilaci","tag-kilo","tag-seker"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/83223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=83223"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/83223\/revisions"}],"predecessor-version":[{"id":83225,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/83223\/revisions\/83225"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/83224"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=83223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=83223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=83223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}